We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+6.27%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$585B
AUM Growth
+$29.3B
Cap. Flow
+$1.02B
Cap. Flow %
0.17%
Top 10 Hldgs %
17.95%
Holding
2,642
New
88
Increased
1,025
Reduced
900
Closed
73

Top Buys

Rank Stock Value
1
GEN icon
Gen Digital
GEN
+$2.03B
2
DD icon
DuPont de Nemours
DD
+$1.83B
3
CCI icon
Crown Castle
CCI
+$1.58B
4
MSFT icon
Microsoft
MSFT
+$1.48B
5
TRU icon
TransUnion
TRU
+$781M

Sector Composition

Rank Sector Weight
1 Healthcare 17.59%
2 Financials 16.53%
3 Technology 15%
4 Consumer Discretionary 13.37%
5 Industrials 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SWBI icon
2576
Smith & Wesson
SWBI
$638M
-12,124
Closed -$207K
TEVA icon
2577
Teva Pharmaceuticals
TEVA
$42.5B
-1,284,800
Closed -$42.7M
TMHC
2578
DELISTED
Taylor Morrison
TMHC
-8,972
Closed -$215K
VCYT icon
2579
Veracyte
VCYT
$3.73B
-21,492
Closed -$179K
VIV icon
2580
Telefônica Brasil
VIV
$18.6B
-1,880,992
Closed -$25.4M
VRNS icon
2581
Varonis Systems
VRNS
$4.84B
-97,986
Closed -$1.22M
VYGR icon
2582
Voyager Therapeutics
VYGR
$197M
-150,384
Closed -$1.35M
TBRG
2583
DELISTED
TruBridge
TBRG
-28,817
Closed -$945K
SCU
2584
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
-61,861
Closed -$1.58M
OTIC
2585
DELISTED
Otonomy, Inc.
OTIC
-777,237
Closed -$14.7M
HMHC
2586
DELISTED
Houghton Mifflin Harcourt Company
HMHC
-30,590
Closed -$376K
WAAS
2587
DELISTED
AquaVenture Holdings Limited
WAAS
-268,943
Closed -$4.1M
GNCA
2588
DELISTED
Genocea Biosciences, Inc.
GNCA
-4,486
Closed -$187K
SNMX
2589
DELISTED
Senomyx, Inc.
SNMX
-221,205
Closed -$184K
CHUBA
2590
DELISTED
CommerceHub, Inc. Series A Common Stock
CHUBA
-68,709
Closed -$1.2M
CHUBK
2591
DELISTED
CommerceHub, Inc. Series C Common Stock
CHUBK
-142,113
Closed -$2.48M
CUDA
2592
DELISTED
Barracuda Networks, Inc.
CUDA
-362,566
Closed -$8.36M
SRUNU
2593
DELISTED
Silver Run Acquisition Corporation II Units
SRUNU
-2,623,720
Closed -$28M
CBF
2594
DELISTED
Capital Bank Financial Corp. Class A Common Stock
CBF
-1,844,682
Closed -$70.3M
CUNB
2595
DELISTED
CU Bancorp
CUNB
-478,418
Closed -$17.3M
WSTC
2596
DELISTED
West Corporation
WSTC
-225,859
Closed -$5.27M
STS
2597
DELISTED
Supreme Industries Inc Class A
STS
-16,736
Closed -$275K
SGBK
2598
DELISTED
Stonegate Bank
SGBK
-24,094
Closed -$1.11M
CAB
2599
DELISTED
Cabela's Inc
CAB
-13,765
Closed -$818K
SHOR
2600
DELISTED
ShoreTel, Inc.
SHOR
-690,951
Closed -$4.01M

Similar funds

T. Rowe Price Associates's Q3 2017 Portfolio in Review

As of Q3 2017, T. Rowe Price Associates held 2,642 positions worth $585B, up 5.3% from $556B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

T. Rowe Price Associates's Q3 2017 filing shows 88 new, 1,025 increased, 900 reduced and 73 closed positions. Its largest new stake was Brighthouse Financial: 4,532,679 shares worth $276M. The largest sale was Du Pont De Nemours E I, an estimated $1.72B.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Financials and Technology.

  • T. Rowe Price Associates's largest Q3 2017 buy was Brighthouse Financial: 4,532,679 shares worth $276M.
  • T. Rowe Price Associates added most to Gen Digital in Q3 2017, an estimated $2.03B increase.
  • T. Rowe Price Associates's biggest Q3 2017 reduction was Starbucks, cutting an estimated $1.59B.
  • T. Rowe Price Associates fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $1.72B.
  • T. Rowe Price Associates's ten largest holdings make up 18% of its $585B portfolio in Q3 2017.
  • T. Rowe Price Associates opened 88 new positions and closed 73 in Q3 2017.
  • T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $585B.

Based on T. Rowe Price Associates's 13F filing for Q3 2017, filed 14 Nov 2017.